| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.006 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |